Board of Directors

Dr. Satish Sawant is a distinguished leader with over 30+ years of exemplary service in the pharmaceutical and contract research organization sectors. Possessing a strong background in both scientific research and business management, Dr. Sawant has been at the forefront of driving innovation and strategic growth initiatives throughout his career. As the Director of Sarth Research Solutions, Dr. Sawant is committed to fostering a culture of excellence and delivering impactful solutions to support pharmaceutical companies across all stages of the product lifecycle, and continuously improve to provide the right solutions for our clients. Dr. Sawant’s illustrious career journey encompasses pivotal roles at esteemed global pharmaceutical companies and contract research organizations.

Dr. Satish Sawant


He holds a PhD in Analytical Chemistry from Mumbai University, underscoring his multidisciplinary approach to leadership and management. Throughout his tenure in the industry, Dr. Sawant has achieved significant milestones and delivered tangible results. At Accutest Research Laboratories (I) Pvt. Ltd., he was the co-founder, CEO and managing director. He has spearheaded and shaped the incredible journey of Accutest as one of leading CRO’s in the industry through his sheer grit, farsighted business strategies and zeal of consistently add value to the research industry. His dynamic vision brought Accutest, from to a leading international and fastest growing CRO with a sustained growth and profitability since its inception more than 25 years ago. Dr. Sawant is an esteemed member of the Indian Pharmaceutical Association (IPA) and Indian Drug Manufacturer’s Association (IDMA). He has been honoured with Indian Achievers Award for the Best CRO, Most Innovative CEOs by Inc. India and the very prestigious Udyog Shree Award in Clinical Research by Government of Maharashtra. His active involvement in these professional organizations underscores his commitment to advancing clinical research and fostering collaboration within the industry.

Mr. Atul Solankar


Mr. Atul Solankar is a dynamic leader with 25 years of extensive experience in the pharmaceutical, biotechnology and contract research organization sectors. Throughout his career, Mr. Solankar has consistently showcased a deep understanding of regulatory requirements and has effectively navigated successful regulatory inspections. His tenure has been marked by numerous accomplishments and contributions, including successful project acquisitions, and regulatory submissions. Mr. Solankar’s extensive experience provides him with valuable insights and strategic foresight, making him a trusted leader in driving business development and regulatory initiatives within the pharmaceutical sector. With a multifaceted background spanning business development, project management, regulatory affairs, medical writing, and quality assurance, Mr. Solankar brings a wealth of knowledge and unique blend of strategic vision and operational excellence to his role as Director at Sarth Research Solutions. 

Leveraging his extensive experience and industry expertise, he plays a pivotal role in shaping the company’s regulatory strategy and forging strategic partnerships to advance drug development efforts. With a distinguished career trajectory, Mr. Solankar has held key executive positions in leading pharmaceutical and contract research companies. Most notably, he served as the President of Business Development, Project Management, Regulatory Affairs, Medical Writing, and Quality Assurance, at CRO, where he led diverse teams in achieving regulatory milestones and driving business growth initiatives. Mr. Solankar holds a Master of Pharmacy in Pharmacology from the University of Mumbai. His strategic leadership has resulted in the successful clinical strategy for 505(b)(2), NCE-1 and submission of multiple First-to-File clinical studies for USFDA. Mr. Solankar’s exemplary contributions to challenging projects such as NCE-1/FTF for US FDA submissions and bio-similar products for ANVISA and EMA submissions, have earned him prestigious recognition in the industry. His unwavering dedication to ensuring regulatory compliance and his exceptional achievements have been appreciated by pharmaceutical companies.

Get a Quote